Benzodiazepines were prescribed widely for PTSD-related anxiety and insomnia for decades before clinical guidelines shifted away from them. Veterans who developed dependence through prescribed treatment may have a viable secondary VA claim, but the legal framework requires careful construction.
Benzodiazepines (diazepam, lorazepam, clonazepam, alprazolam, and others) produce rapid anxiolytic and hypnotic effects by enhancing the activity of GABA receptors in the brain. For veterans struggling with hyperarousal, panic, and severe insomnia, they provided faster relief than antidepressants.
VA and DoD prescribing patterns from the 1980s through the 2000s included frequent benzodiazepine use for PTSD management. Published psychiatric literature now shows that long-term benzodiazepine use carries a high dependence risk, with physical withdrawal symptoms that can be life-threatening if not properly managed. Many veterans prescribed these medications for legitimate PTSD treatment developed physiological dependence as a direct result.
Current VA and DoD clinical practice guidelines advise against benzodiazepines for PTSD because of this dependence risk. But that shift in guidelines doesn't help the veteran who was prescribed them years ago under an earlier standard of care.
Allen v. Principi (237 F.3d 1368, Fed. Cir. 2001) established that substance use disorder is service-connectable as a secondary condition when proximately caused by a service-connected diagnosis. The willful misconduct bar does not apply when the SUD arose from the service-connected condition rather than from independent volitional conduct.
Benzodiazepine dependence that developed from prescribed treatment for service-connected PTSD fits this framework:
This is an iatrogenic claim, similar in structure to opioid use disorder secondary to chronic pain. The veteran followed medical instructions. The dependence was a foreseeable consequence of the prescribed treatment.
This distinction matters for the claim. Physiological dependence on prescribed benzodiazepines is not the same as recreational misuse. The DSM-5 recognizes this distinction: tolerance and withdrawal from prescribed medications are not themselves counted toward a sedative, hypnotic, or anxiolytic use disorder diagnosis when they occur in the context of appropriate medical use.
The claim should frame the condition accurately:
A psychiatrist or addiction medicine specialist should formally evaluate and document the diagnosis before the nexus letter is commissioned.
A formal diagnosis of benzodiazepine dependence or sedative, hypnotic, or anxiolytic use disorder from a VA or private psychiatrist or addiction medicine provider.
The physician-authored opinion must address:
Like other SUD diagnoses, benzodiazepine dependence is rated 0% under the special rule in 38 CFR 4.130. The value lies in treatment access and potential tertiary claims from benzodiazepine-related conditions, including cognitive changes and sleep architecture disruption.
See the real value of SUD service connection despite 0% rating for why the 0% outcome doesn't mean the claim isn't worth filing.
Veterans with benzodiazepine dependence secondary to PTSD may have additional overlapping claims worth evaluating carefully.
For example: a veteran with benzodiazepine dependence secondary to PTSD who also has documented sleep architecture disruption from long-term benzodiazepine use may have a viable insomnia claim under a separate diagnostic code. Chronic insomnia with documented functional impairment (daytime fatigue, occupational consequences, difficulty maintaining restorative sleep independent of the underlying PTSD) can be rated separately if it produces disability distinct from the PTSD rating.
Similarly, cognitive changes from long-term benzodiazepine exposure can produce measurable impairment in memory and processing speed that is separate from the anxiety and mood symptoms of PTSD. These may be ratable under organic mental disorder codes if formally evaluated with neuropsychological testing.
The key caveat is that ratings for conditions that overlap heavily with PTSD require careful structuring to avoid rating conflicts. A VSO or accredited claims agent familiar with mental health claim combinations should review these before filing.
If you developed benzodiazepine dependence from prescribed PTSD treatment, a physician-authored nexus letter is the key document in your claim. Flat Rate Nexus provides independent medical opinions addressing the Allen v. Principi framework. Educational resources are available at flatratenexus.com/substance-use-disorder.html.
Thinking about your own claim? Every nexus letter we write goes through a full physician record review, cites peer-reviewed research, and is built around the actual evidence in your case.
Start My Nexus Letter